Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hiroki Ishihara
Institutions:
Tokyo Women's Medical University Hospital,
Tokyo Women's Medical University,
Saiseikai Kawaguchi General Hospital
Observed institutions:
Tokyo Women's Medical University Hospital,
Tokyo Women's Medical University,
Saiseikai Kawaguchi General Hospital
ORCID:
0000-0002-5146-656X
Observed ORCID:
0000-0002-5146-656X
OpenAlex ID:
A5123986233
Midterm Outcomes of Combination Therapy With Immune Checkpoint Inhibitors and VEGFR ‐ TKIs in Real‐World Patients With Advanced Renal Cell Carcinoma
2026
·
Hiroki Ishihara
, Nanaka Katsurayama
, et al.
·
International Journal of Urology
·
5
PDF
Anti‐Melanoma Differentiation‐Associated Gene 5 Antibody‐Positive Interstitial Lung Disease, Induced by Enfortumab Vedotin Plus Pembrolizumab for Advanced Urothelial Carcinoma
2026
·
Akira Saito
, Hiroki Ishihara
, et al.
·
IJU Case Reports
·
2
PDF
Non–Clear Cell Renal Cell Carcinoma Has an Immune-Cold Phenotype That Affects Response to Immune Checkpoint Inhibitors
2026
·
Hiroki Ishihara
, Yu-Yu Liu
, et al.
·
Molecular Cancer Research
·
2
Real-World Outcomes of Adjuvant Pembrolizumab for Renal Cell Carcinoma: The Potential Role of PD-L1 as a Prognostic Biomarker
2026
·
Hiroki Ishihara
, Takayuki Nakayama
, et al.
·
Targeted Oncology
·
1
PDF
Real-world outcomes of third-line systemic therapy after immune checkpoint inhibitor combinations and subsequent VEGFR-TKIs in advanced renal cell carcinoma
2026
·
Hiroki Ishihara
, Koichi Nishimura
, et al.
·
Japanese Journal of Clinical Oncology
·
1
Future direction of systemic therapy for advanced renal cell carcinoma: lessons from final and extended follow-up data from the CheckMate 9ER trial
2026
·
Hiroki Ishihara
·
Translational Andrology and Urology
Association of serum kidney injury molecule-1 with treatment response and survival in metastatic renal cell carcinoma.
2026
·
Akihiro Kumono
, Hironori Fukuda
, et al.
·
Journal of Clinical Oncology
PDF
Immunological clustering from peripheral blood to define prognosis and T cell exhaustion profiles in renal cell carcinoma.
2026
·
Hanae Kondo
, Hironori Fukuda
, et al.
·
Journal of Clinical Oncology
Impact of Cytoreductive Nephrectomy on Immune Checkpoint Inhibitor Therapy: Treatment Outcomes of Immune Inhibitors Combination Therapies for Metastatic Renal Cell Carcinoma With Primary Kidney Tumors
2026
·
Yuki Nemoto
, Hiroki Ishihara
, et al.
·
International Journal of Urology
PDF
Show more works
View as search
Works count:
9
Citation count:
11
H-index:
2
I10-index:
Year
Topic
Type